» Articles » PMID: 27323833

National Incidence of Autoimmune Liver Diseases and Its Relationship with the Human Development Index

Overview
Journal Oncotarget
Specialty Oncology
Date 2016 Jun 22
PMID 27323833
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), autoimmune hepatitis (AIH) and immunoglobulin G4 related cholangitis represent the major autoimmune liver diseases (AILD). However, the relationship between AILD incidence and socioeconomic development levels is yet to be explored.

Results: A total of 43 studies were included. There was a positive but not significant correlation between the PBC incidence and HDI on a global level (r=0.348, P=0.082). However, in Europe, a significantly positive correlation existed between the PBC incidence and HDI (r=0.455, P=0.044). No statistical correlation between PSC incidence and HDI was observed (r=0.116, P=0.706). The incidence of AIH revealed a positive correlation with the national HDI both globally (r=0.638, P=0.014) and in Europe (r=0.644, P=0.045). Moreover, the PBC incidence demonstrated a positive correlation with the health index (r=0.422, P=0.036), but a negative correlation with the education index (r= -0.650, P<0.01). Moreover, the income index presented a positive correlation with both the PSC incidence (r=0.599, P=0.031) and the AIH incidence (r=0.649, P=0.012).

Methods: PubMed was searched to identify relevant epidemiological studies on AILD. The human development index (HDI) was applied as an indicator for socioeconomic development. HDI data were obtained and calculated based on the 2014 Human Development Report. Pearson coefficient and linear regression analysis were conducted to estimate the correlation between incidence and HDI.

Conclusions: There is positive association between the national incidence of AILD and the socioeconomic status, as measured by HDI. In less-developed countries, the incidence of AILD, especially PBC and AIH, might be less common.

Citing Articles

Socioeconomic determinants of global distribution of multiple sclerosis: an ecological investigation based on Global Burden of Disease data.

Kazemi Moghaddam V, Dickerson A, Bazrafshan E, Seyedhasani S, Najafi F, Hadei M BMC Neurol. 2021; 21(1):145.

PMID: 33794796 PMC: 8015140. DOI: 10.1186/s12883-021-02170-3.


New developments in the treatment of primary biliary cholangitis - role of obeticholic acid.

Jhaveri M, Kowdley K Ther Clin Risk Manag. 2017; 13:1053-1060.

PMID: 28860789 PMC: 5572954. DOI: 10.2147/TCRM.S113052.


Recent advances in the diagnosis and treatment of primary biliary cholangitis.

Huang Y World J Hepatol. 2016; 8(33):1419-1441.

PMID: 27957241 PMC: 5124714. DOI: 10.4254/wjh.v8.i33.1419.

References
1.
Escorsell A, Pares A, Rodes J, Solis-Herruzo J, Miras M, De la Morena E . Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver. J Hepatol. 1994; 21(5):787-91. DOI: 10.1016/s0168-8278(94)80240-8. View

2.
Almdal T, Sorensen T . Incidence of parenchymal liver diseases in Denmark, 1981 to 1985: analysis of hospitalization registry data. The Danish Association for the Study of the Liver. Hepatology. 1991; 13(4):650-5. View

3.
Boonstra K, Kunst A, Stadhouders P, Tuynman H, Poen A, van Nieuwkerk K . Rising incidence and prevalence of primary biliary cirrhosis: a large population-based study. Liver Int. 2014; 34(6):e31-8. DOI: 10.1111/liv.12434. View

4.
Kim W, Lindor K, Locke 3rd G, Therneau T, Homburger H, Batts K . Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology. 2000; 119(6):1631-6. DOI: 10.1053/gast.2000.20197. View

5.
Alvarez F, Berg P, Bianchi F, Bianchi L, Burroughs A, Cancado E . International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999; 31(5):929-38. DOI: 10.1016/s0168-8278(99)80297-9. View